ABSTRACT Two monoclonal antibodies, prepared against a murine B lymphoma and characterized as binding to a cell surface antigen represented primarily on cells ofthe B lineage, were found to bind to human hemopoietic cells. These antibodies recognize similar populations of cells in mice and humans. Antibodies from clones 177.17 and 83.4 bound to 6% of human bone marrow nucleated cells. This included all cells with detectable cell surface Ig (sIg') and those that lack sIg but have detectable cytoplasmic ,u (sIg, cIA+), considered to be the immediate precursors of B lymphocytes (pre-B cells). In addition, these antibodies bound to a subpopulation of T cells and a proportion of null lymphocytes in marrow, spleen, and peripheral blood. An unexpected finding was that established pre-B cell lines were not recognized by these antibodies and possible reasons for this are considered. By using antibody-coated polystyrene plates for cell depletion and recovery, highly enriched preparations of ciA+, sIg-cells have been obtained. These antibodies and enrichment procedures should prove valuable in establishing the minimal requirements for maturation of these putative precursors in vitro, for comparative studies of immunodeficiency/autoimmune diseases in man and experimental animal models, and for monitoring the outcome of therapeutic marrow transplantation.
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A panel ofmonoclonal rat antibodies was recently prepared and characterized as directed to determinants on murine cells of B cell lineage. One group of seven clones produced antibodies that did not recognize immunoglobulin and that similarly bound to a series of established murine cell lines. Five of these made antibodies ofsatisfactory avidity and were studied in detail. The antigen(s) recognized by these antibodies is displayed on most B cells, a subpopulation of peripheral T cells, and a proportion of antibody-secreting cells (1) . In addition, cell surface immunoglobulin negative (sIg-) lymphoid cells that are found from an early stage in fetal liver and during postnatal life in adult marrow are recognized and can be substantially enriched with these antibodies. Such populations include cytoplasmic ,u+ (cqu+), surface Ig-immediate precursors ofB lymphocytes (pre-B), and precursors capable of rapidly giving rise to functional B cells in culture or after transfer to irradiated, immunodeficient recipients (1, 2) . Virtually no antigen-bearing cells were found in normal thymus. Brain, erythrocytes, granulocytes, macrophages, hemopoietic stem cells (CFU-s), myeloid progenitor cells (CFU-c), mastocytoma cells, and erythroleukemia cells did not have detectable amounts of antigen.
A number ofcell surface molecules that were originally identified on murine leukocytes have been found to be analogous to human antigens. Often the basic structures-and in some cases even the cellular distributions-of these have been comparable, and there are several recent examples in which heteroantibodies and alloantibodies were found to detect conserved antigen determinants (3) (4) (5) (6) (7) (8) (9) .
We report here that two of our monoclonal antibodies that were prepared against murine cells bind also to human leukocytes and do so with remarkably similar selectivity for lymphocyte sets. Furthermore, these reagents can be used in the same way as with murine cells to obtain highly enriched preparations of sIg-human marrow lymphocytes.
MATERIALS AND METHODS
Cell Suspensions. Peripheral blood and bone marrow cells were obtained from healthy adult volunteers. Histologically normal spleen samples were obtained following therapeutic splenectomy. Peripheral blood mononuclear cells were prepared by using Ficoll/Paque according to manufacturer's directions (Pharmacia). Enriched granulocytes were recovered from the pellets resulting from this procedure by lysis with Trisbuffered 0.15 M NH4Cl at pH 7.4. Generally bone marrow cells were diluted in medium and spun down once at room temperature. The cells were then taken up in 100% fetal calf serum (serum, 3 ml) and mixed with buffered NH4C1 solution (10 ml) and held at 4°C until satisfactory erythrocyte lysis was achieved. Usually 10-15 min were required for lysis and loss ofnucleated cells was insignificant. The cells were then washed extensively in medium containing 5% serum and counted. Spleen samples were dispersed into single cell suspensions by passage through stainless steel wire screens, freed ofdebris, and handled exactly the same as peripheral blood samples.
Antibodies. The monoclonal rat anti-mouse B lineage antibodies used in this report are described in detail elsewhere (1) .
The M1/70 (anti-Mac-i) clone (10) (Fig. 1) . The Of the human B lymphocyte markers that have been described, the one detected by our antibodies most closely resembles one recently described by. Dalchau and Fabre (16) . They found that a high molecular weight (Mr 217,000) glycoprotein was recognized by their monoclonal antibodyfrom clone F8-11-13 and that this molecule also carried common leukocyte It is intriguing to note that only two of seven antibodies that bind to the murine antigen are crossreactive with the human analog. Thus, our panel detects multiple determinants on the murine antigen, at least one ofwhich has been evolutionarily conserved. Analogies can also be drawn between peripheral T cell populations of mouse and man that are detected by these antibodies. In normal murine lymph nodes practically all of the cells distinguished by having easily detectable Lyt-2 but a low density of Lyt-1 alloantigens are also labeled by our panel of antibodies (1) . A much smaller percentage of the Lyt-l+, Lyt-2-, Thy-l+ cells in the same tissues is also recognized and these account for the striking lymphadenopathy ofautoimmune MRL/ Lpr mice (unpublished data). Normal human lymph node cells were not available for the present study but there was some preference for recognition of the Leu-2-bearing subset of peripheral blood T cells (Table 2 ). This marker is biochemically similar to the murine Lyt-2 antigen and similarly is associated with cytotoxicity and suppressor functions (18) .
There is considerable indirect information about processes that immediately precede the surface IgM display and concomitant acquisition offunctional capability by newly formed B cells (19) . It is thought that these cells first synthesize kL heavy chains of IgM that can be detected by cytoplasmic immunofluorescence of fixed cell preparations (20) . Virtually all cells with this phenotype were included in sIg-marrow populations selected with dishes coated with 177.17 antibody (Table 4) . Suspensions of cells similarly enriched from murine fetal liver or bone marrow go on to display sIgM and respond in various assays during culture (unpublished data). Furthermore, sIgM display can be "induced" on an established murine pre-B cell line with these characteristics by incubation in the presence of lipopolysaccharide (21) . However It is possible that cells that originally had this surface antigen lost it with continuous propagation. This may also account for the finding that one human and several murine B cell lines are negative and it is consistent with the finding that several human cell lines lack histocompatibility antigens (24) . However, unless our sample of cell lines is not representative, the marker must be more commonly lost from immature cells. A more interesting possibility is that the pre-B cells that are subject to transformation in vivo or in vitro normally (or abnormally) lack the antigen detected by our antibodies. An analysis of marrow specimens from patients with diagnosed pre-B ALL could be informative in this respect. In addition, the reagents and enrichment procedures described here should also prove useful for studies of immunodeficiency diseases and for monitoring the outcome of bone marrow transplantation.
